B-cell receptor pathobiology and targeting in NHL
Ines M Macias-Perez1, Ian W Flinn
1Sarah Cannon Research Institute, 3322 West End Avenue, Suite 900, Nashville, TN, 37203, USA. ines.macias-perez@scresearch.net
Current Oncology Reports
|August 7, 2012
Summary
Novel therapies targeting B-cell receptor signaling are crucial for treating non-Hodgkin's lymphoma. Understanding this pathway offers new therapeutic targets like Syk and BTK for resistant disease.
Area of Science:
- Immunology
- Oncology
- Pharmacology
Background:
- B-cell receptor (BCR) signaling is vital for B-cell development, homeostasis, and disease pathogenesis.
- Dysregulation of BCR signaling contributes to the development and progression of various lymphoid malignancies.
- Non-Hodgkin's lymphoma (NHL) incidence is rising, highlighting the need for improved therapeutic strategies.
Purpose of the Study:
- To review contemporary findings on novel agents targeting the BCR signaling pathway.
- To discuss the clinical development of new therapeutics for non-Hodgkin's lymphoma.
- To emphasize the role of BCR pathway inhibitors in managing resistant disease.
Main Methods:
- Literature review of recent scientific research and clinical trial data.
- Analysis of key signaling molecules within the BCR pathway, including Syk, BTK, and PI3K.
- Focus on novel therapeutic agents and their mechanisms of action.
Main Results:
- Identification of key players and modulators in BCR signaling.
- Understanding of BCR pathway dysregulation in B-cell malignancies.
- Clinical development of targeted therapies like Syk and BTK inhibitors.
Conclusions:
- Targeting the BCR signaling pathway represents a promising therapeutic avenue for NHL.
- Novel agents offer new hope for patients with resistant or refractory disease.
- Continued research into BCR pathobiology will yield further therapeutic innovations.
Related Concept Videos
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
01:28Diversity of Antigen Receptors
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
01:36Humoral Immune Responses
Overview
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:23Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
01:20Special Features of Adaptive Immunity
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...